Plasma and cerebrospinal fluid endogenous digoxin-like immunoreactivity in patients with aneurysmal subarachnoid haemorrhage

Acta Neurochirurgica

Volumn 141, Issue 7, 1999, Pages 691-697

  Lušić, Ivo ^a   Ljutic D ^a   Maskovic J ^a   Jankovic S ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

Arterial vasospasms; Digoxin like immunoreactive substance; Subarachnoid haemorrhage

Indexed keywords

DIGITALIS LIKE FACTOR; DIGOXIN;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ARTERY ANEURYSM; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN SYNTHESIS; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; CARDENOLIDES; DIGOXIN; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; INTRACRANIAL ANEURYSM; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; PROSPECTIVE STUDIES; SAPONINS; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032801818     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010050363     Document Type: Article

References (52)

1. 3H)ouabain binding in rat resistance vessels. J Physiol 362: 215-231
2. 2. Allen GS, Henderson LM, Chou SN (1974) Cerebral arterial spasm. part 1: In vitro contraction of vasoactive agents on canine basilar and middle cerebral arteries. J Neurosurg 40: 433-441
3. 3. Allonen H, Anderson KE, Iisalo E, Kanto J, Stromblad LG, Wettrell G (1977) Passage of digoxin into cerebrospinal fluid in man. Acta Pharmacol Toxicol 41(3): 193-202
4. 4. Biller J, Godersky JC, Adams HP (1988) Management of aneurysmal subarachnoid hemorrhage. Stroke 10: 1300-1305
5. 5. Bonelli J, Ramcis H, Waginger H (1981) Digoxin concentration in cerebrospinal fluid - a study carried out after 9 days of treatment of beta methyldigoxin or beta-acetyldigoxin. Int J Clin Pharmacol Ther Toxicol 19(3): 93-95
6. 6. Brodal A (1981) Neurological anatomy in relation to clinical medicine. Oxford University Press, New York Oxford, pp 726-754
7. 7. Budzikowski AS, Leenen FH (1997) Brain 'ouabain' in the median preoptic nucleus mediates sodium-sensitive hypertension in spontaneously hypertensive rats. Hypertension 29(2): 599-605
8. 8. Gaetani P, Marzatico F, Baena RR i sur (1990) Arachidonic acid metabolism and patophysiologic aspects of subarachnoid hemorrhage in rats. Stroke 21: 328-332
9. 9. Gasic S. Eichler HG, Korn A (1987) Effect of calcium antagonists on basal and digitalis-dependent changes in splanchnic and systemic hemodynamics. Clin Pharmacol Ther 41: 460-466
10. 10. Gilson GJ, Graves SW, Qualls CR, Curet LB (1997) Digoxin-like immunoreactive substance and sodium-potassium-adenosine triphosphatase inhibition in normal pregnancy: a longitudinal study. Obstet Gynecol 89(5 Pt 1): 743-746
11. 11. Goto A, Ishiguro T, Yamada K et al (1990) Isolation of a urinary digitalis-like factor indistinguishable from digoxin. Biochem Biophys Res Commun 173: 1093-10101
12. 12. Graf CJ, Nibbelink DW (1981) Randomized treatment study. Intracranial surgery. In: Sahs AI, Nibbelink DW, Torner JC (eds) Aneurysmal subarachnoid hemorrhage. Urban & Schwarzenberg, Baltimore, pp 170-175
13. + pump in human cerebrospinal fluid. J Neurol Sci 90(2): 217-230
14. 14. Hamlyn JM, Hamilton BP, Manunta P (1996) Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J Hypertens 14: 151-167
15. 15. Hamlyn JM, Blaustein MP, Bova S, Du Charme DW, Harris DW, Mandel F, Mathews WR, Ludens JH (1991) Identification and characterisation of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA 88: 6259-6263
16. 16. Hayward JN (1975) Neural control of the posterior pituitary. Ann Rev Physiol 37: 191-210
17. 17. Holmes RL, Ball JN (1974) The pituitary gland. A comparative account. Cambridge Univ Press, London
18. 18. Ihara N, Yuri K, Yamada H, Sano Y (1988) Immunohistochemical studies on the distribution of endogenous digitalis-like substance (EDLS)-containing neurons in the rat hypothalamus, with special consideration on the possibility of their coexistence with posterior lobe hormones. Arch Hist Cytol 51: 35-42
19. 19. Iversen LL (1971) Role of transmiter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 41: 571-591
20. 20. Jandhyala BS, Lokhandwala MF, Kivlighin SD, Ansari AF, DeFeo ML (1987) Intracisternal administration of pergolyde, a dopamine receptor agonist, triggers the release of an inhibitor of ouabain-sensitive sodium, potassium-dependent adenosine triphosphatase and enhances vascular reactivity. Clin Sci 73: 183-188
21. 21. Jortani SA, Valdes R Jr (1997) Digoxin and its related endogenous factors. Crit Rev Clin Lab Sci 34(3): 225-274
22. 22. Juvela S, Hillbom M, Kiste M. Platelet tromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. J Neurosurg 74: 386-392
23. 23. Kassel NF, Shaffrey ME, Shaffrey CI (1995) Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. In: Apuzzo MLJ (ed) Brain surgery. Churchill Livingstone, New York, pp 847-856
24. 24. Kranzhofer R, Haas M, Kurz T, Richardt G, Schomig A (1991) Effect of digitalis glycosides on norepinephrine release in the heart. Circ Res 68: 1628-1637
25. 25. Krivoy N, Lalkin A, Jakobi P (1990) Digoxin-like immunoreactivity detected in cerebrospinal fluid of humans with fever [letter]. Clin Chem 36(4): 703-704
26. 26. Laredo J, Shah JR, Lu ZR, Hamilton BP, Hamlyn JM (1997) Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via agiotensin type 2 receptors. Hypertension 29(1 Pt 2): 401-407
27. 27. Lichtstein D, Mine D, Bourrit A, Deutsch J, Karlish SJ, Belmaker H, Rimon R, Palo J (1985) Evidence for the presence of 'ouabain like' compound in human cerebrospinal fluid. Brain Res 325(1 2): 13-19
28. 28. Lušić I (1998) Immunoreactive digoxin-like substances in plasma and cerebrospinal fluid of patients with stroke. Disertation Zagreb: medicinski fakultet sveučilišta u Zagrebu
29. 29. Martinka E, Galajada P, Ochodnicky M, Lichardus B, Straka S, Mokan M (1997) Endogenous digoxin-like immunoactivity and diabetes mellitus: facts and hypotheses. Med Hypo 49: 271-275
30. 30. Mayberg MR (1998) Cerebral vasospasm. Neurosurg Clin North Am 9: 615-627
31. 31. Pasqualin A, Cavazzani P, Scienza R, Rosta L, Da Pian R (1985) Early computed tomography for prediction of vasospasm after aneurysmal rupture: Experience with 364 cases. In: Aure LM (ed) Timing of aneurysm surgery. Walter de Gruyter, Berlin New York, pp 23-32
32. 32. Pedrinelli R, Taddei S, Salvetti A (1989) Sympathetic vasosconstriction as a mechanism of action of ouabain in forearm arterioles of hypertensive patients. Clin Sci 77: 541-545
33. 33. Petersson J, Ryman T, Hogestatt ED (1993) Enhancement of depolarization-induced contractions after endothelium denudation is not related to an impaired production of nitric oxide or prostacyclin in the rabbit basilar artery. Acta Physiol Scand 149: 467-474
34. 34. Pickering BT The molecules of neurosecretion: their formation, transport and release. In: Corner M, Swaab DF (eds) Perspectives in brain research, progress in brain research. Elsevier, Amsterdam, pp 161-179
35. 35. Sano K (1983) Cerebral vasospasm and aneurysm surgery. Clin Neurosurg 30: 13-51
36. 36. Sato K, Aoki K (1991) Early and late contraction induced by ouabain in human umbilical arteries. Br J Pharmacol 103: 1525-1529
37. 37. Sciler RW, Aaslid R, Grolimund P (1985) Correlation of the middle cerebral artery flow velocity with the clinical course and CT-visualised subarachnoid blood in patients after aneurysmal subarachnoid haemorrhage. In: Aure LM (ed) Timing of aneurysm surgery Walter de Gruyter, Berlin New York, pp 429-435
38. 38. Shepherd JT, Vanhoutte PM (1985) Spasm of the coronary arteries: causes and consequences (the scientist's viewpoint). Mayo Clin Proc 60: 33-46
39. 39. Songu-Mize E, Bealer SL, Hassid AI (1990) Centrally administered ANF promotes appearance of a circulating sodium pump inhibitor. Am J Physiol 258: H1655-H1659
40. 40. TDxFLx Assays Manual (1985) Chicago: Abott Laboratories, USA 2·6 (R-101)
41. 41. Teruya H, Yamazato M, Muratani H, Sakima A, Takishita S, Terano Y, Fukiyama K (1997) Role of ouabain-like compound in the rostral ventrolateral medulla in rats. J Clin Invest 99(11): 2791-2798
42. 42. Tettenborn D, Dycka J (1990) Prevention and treatment of delayed ischemic disfunction in patients with aneurysmal subarachnoid hemorrhage. Stroke 21 [Suppl] IV: 85-89
43. 43. Toda N (1983) Alpha adrenergic receptor subtype in human, monkey and dog cerebral arteries. J Pharmacol Ex Ther 226: 861-868
44. 44. Toda N (1988) Hemolysate inhibits cerebral artery relaxation. J Cereb Blood Flow Metab 8: 46-53
45. 45. White RP, Hagen AA, Morgan H et al (1975) Experimental study on the genesis of cerebral vasospasm. Stroke 6: 52-55
46. 46. Wijdicks EFM, Vermeulen M, van Brummelen P, den Boer NC, van Gijn J (1987) Digoxin-like immunoreactive substance in patients with aneurysmal subarachnoid haemorrhage. Br Med J 294-729
47. 47. Woolfson RG, Poston L, de Wardener HE (1994) Digoxin-like inhibitors of active sodium transport and blood pressure: the current status. Kidney Int 46: 297-309
48. 48. Yamada H, Ihara N, Takahashi H, Yoshimura M, Sano Y (1992) Distribution of the endogenous digitalis-like substance (EDLS) containing neurons labelled by digoxin antibody in hypothalamus and three circumventricular organ of dog and macaque. Brain Res 584: 237-243
49. 49. Yamada K, Goto A, Nagoshi H, Hui C, Omata M (1994) Role of brain ouabainlike compound in central nervous system-mediated natriuresis in rats. Hypertension 23: 1027-1031
50. 50. Yamazato M, Muratani H, Fukiyama K (1997) Endogenous digitalis-like factor. Nippon Rinsho 55(8): 1971-1976
51. 51. Yokota M, Tani E, Maeda Y (1989) Biosynthesis of leukotrienes in canine cerebral vasospasm. Stroke 20: 527-533
52. 52. Zervas NT, Lavyne MH, Negoro M (1975) Neurotransmiters and the normal and ischemic circulation. N Eng J Med 293: 812-816